News

Dr David Tovey, Editor-in-Chief, Cochrane, said: "We now have the most robust, comprehensive review on 'neuraminidase inhibitors' that exists. Initially thought to reduce hospitalisations and ...
The use of amantadates for the prevention and treatment of influenza A is more cost-effective than neuraminidase inhibitors; however, they are not effective against influenza B. For this reason ...
The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO ...
The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO ...
In February 2024, dairy farmers in Texas began noticing their cows were producing less milk and that the milk was discoloured ...
The WHO recommends neuraminidase inhibitors for patients with H5N1 influenza and their contacts because oseltamivir is active against H5N1 influenza and there are no alternative treatments.
Roche is hoping the new drug can breathe new life into its flu franchise, represented by older neuraminidase inhibitor Tamiflu (oseltamivir). That was a $3 billion brand at its peak, but has ...
the agency also noted that genetic sequencing from cases at poultry farms in Washington had identified a change that could reduce influenza viruses’ susceptibility to neuraminidase inhibitor ...